Tesofensine 500mcg Tablets (100 Count)

$168.00

Tesofensine 500mcg tablets: 100 tablets with 500mcg of Tesofensine in each. No reconstitution and no fridge needed, just a cool, dry shelf. Independent Janoshik test reports are in the product photos.

For laboratory research use only.

SKU: EZP-TESO-TAB100 Categories: ,

Description

Tesofensine 500mcg tablets from EZ Peptides: a bottle of 100 tablets with 500mcg of Tesofensine in each, for oral-route research. Tesofensine is a triple reuptake inhibitor. Tablets need no reconstitution. They’re sold for laboratory research only.

Tesofensine at a glance

Tesofensine is a phenyltropane triple reuptake inhibitor of serotonin, noradrenaline and dopamine, developed by NeuroSearch in Denmark. It was first studied in Parkinson’s and Alzheimer’s disease.

Weight loss in those trials shifted its development toward obesity.

How Tesofensine acts in the lab

Tesofensine blocks the reuptake transporters for three brain chemicals: serotonin, noradrenaline and dopamine. With reuptake blocked, more of each stays active at the synapse.

Raising noradrenaline and dopamine signaling in appetite circuits is thought to explain the reduced food intake seen in trials. It has a long half-life of several days.

Tesofensine 500mcg tablets technical data

  • Compound: Tesofensine
  • CAS number: 195875-84-4
  • Molecular formula: C17H23Cl2NO
  • Molar mass: 328.3 g/mol
  • Structure: phenyltropane small molecule
  • Amount: 500mcg per tablet, 100 tablets per bottle
  • Form: oral tablets
  • SKU: EZP-TESO-TAB100
  • Use: laboratory research only

What the research says about Tesofensine

Astrup and colleagues reported in The Lancet (2008) a phase 2 trial with up to about 11% weight loss over 24 weeks.

Raised heart rate and blood pressure were noted at higher doses.

To read the papers yourself, start with this PubMed search for Tesofensine.

About the Tesofensine tablet format

Each bottle has 100 tablets at 500mcg, which is 50mg of Tesofensine in total. Tablets suit oral-route studies, and they skip reconstitution, cold storage and syringes.

Keep the bottle closed, somewhere cool and dry, away from direct sunlight. No fridge needed.

Tesofensine 500mcg tablets lab reports

We’ve put the lab paperwork for Tesofensine 500mcg tablets in the image gallery: one Janoshik Analytical report. Each one lists the compound found, the measured amount and the HPLC purity, plus the batch number and the date the lab ran it.

Tesofensine 500mcg tablets Janoshik test report showing HPLC purity

Every Janoshik report has a unique key printed at the bottom. Enter it at janoshik.com/verify and you’ll see the same report straight from the lab, which is the easiest way to know a COA hasn’t been edited. Match the batch on the report with the batch on your label.

Compounds often ordered with Tesofensine

Browse the full weight loss peptides range, or see everything on our research peptides page.

Tesofensine 500mcg tablets FAQ

How much is in the Tesofensine 500mcg tablets bottle?

100 tablets of 500mcg each. The amount is printed on the label.

Is Tesofensine 500mcg tablets lab tested?

Yes. The Janoshik reports are in the product photos, and you can verify each one on janoshik.com with the key printed at the bottom.

Does Tesofensine 500mcg tablets need mixing?

No. Tablets are ready to use, with no reconstitution and no syringes.

How should I store it?

Somewhere cool and dry with the lid closed. Tablets don’t need a fridge.

Can Tesofensine be used in people or animals?

No. It’s sold for laboratory research only and isn’t approved for human or veterinary use.

Buy Tesofensine 500mcg tablets online

Ready to order? Tesofensine 500mcg tablets costs $168.00 a bottle and is in stock. Add it to your cart and you’re done.

Need more for the same project? See the rest of our weight loss peptides.

For laboratory research use only. Not for human or veterinary use. Not evaluated by the FDA.

Reviews

There are no reviews yet.

Be the first to review “Tesofensine 500mcg Tablets (100 Count)”

Your email address will not be published. Required fields are marked *